SCYNEXIS Inc (SCYX)
2.23
+0.26
(+13.20%)
USD |
NASDAQ |
May 15, 14:35
SCYNEXIS Debt to Equity Ratio: 0.00 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.1666 |
| September 30, 2023 | 0.1284 |
| June 30, 2023 | 0.1249 |
| March 31, 2023 | -1.540 |
| December 31, 2022 | 14.04 |
| September 30, 2022 | 2.626 |
| June 30, 2022 | 0.9841 |
| March 31, 2022 | 1.144 |
| December 31, 2021 | 0.978 |
| September 30, 2021 | 1.047 |
| June 30, 2021 | 1.249 |
| March 31, 2021 | 0.4716 |
| December 31, 2020 | 0.7257 |
| September 30, 2020 | 1.389 |
| June 30, 2020 | 2.882 |
| March 31, 2020 | 1.720 |
| December 31, 2019 | 0.8935 |
| September 30, 2019 | 2.047 |
| June 30, 2019 | 1.403 |
| March 31, 2019 | 1.615 |
| Date | Value |
|---|---|
| December 31, 2018 | 0.483 |
| September 30, 2018 | 0.5368 |
| June 30, 2018 | 0.5598 |
| March 31, 2018 | 0.4007 |
| December 31, 2017 | 0.6844 |
| September 30, 2017 | 0.5337 |
| June 30, 2017 | 0.4565 |
| March 31, 2017 | 0.428 |
| December 31, 2016 | 0.4093 |
| September 30, 2016 | 0.427 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -0.7344 |
| December 31, 2013 | -0.7159 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.540
Minimum
Mar 2023
14.04
Maximum
Dec 2022
1.624
Average
1.016
Median
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 6.294 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 118.25M |
| Total Liabilities (Quarterly) | 44.15M |
| Shareholders Equity (Quarterly) | 74.10M |
| Current Ratio | 3.718 |
| Net Debt Paydown Yield | 16.35% |